+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Impact of subdomain D1 of the short form S1b of the human prolactin receptor on its inhibitory action on the function of the long form of the receptor induced by prolactin



Impact of subdomain D1 of the short form S1b of the human prolactin receptor on its inhibitory action on the function of the long form of the receptor induced by prolactin



Biochimica et Biophysica Acta 1840(7): 2272-2280



Long-form (LF) homodimers of the human prolactin receptor (PRLR) mediate prolactin's diverse actions. Short form S1b inhibits the LF function through heterodimerization. Reduced S1b/LF-ratio in breast cancer could contribute to tumor development/progression. Current work defines the structural and functional relevance of the D1 domain of S1b on its inhibitory function on prolactin-induced LF function. Studies were conducted using mutagenesis, promoter/signaling analyses, bioluminescence resonance energy transfer (BRET) and molecular modeling approaches. Mutation of E69 in D1 S1b or adjacent residues at the receptor surface near to the binding pocket (S) causes loss of its inhibitory effect while mutations away from this region (A) or in the D2 domain display inhibitory action as the wild-type. All S1b mutants preserved prolactin-induced Jak2 activation. BRET reveals an increased affinity in D1 mutated S1b (S) homodimers in transfected cells stably expressing LF. In contrast, affinity in S1b homodimers with either D1 (A) or D2 mutations remained unchanged. This favors LF mediated signaling induced by prolactin. Molecular dynamics simulations show that mutations (S) elicit major conformational changes that propagate downward to the D1/D2 interface and change their relative orientation in the dimers. These findings demonstrate the essential role of D1 on the S1b structure and its inhibitory action on prolactin-induced LF-mediated function. Major changes in receptor conformation and dimerization affinity are triggered by single mutations in critical regions of D1. Our structure-function/simulation studies provide a basis for modeling and design of small molecules to enhance inhibition of LF activation for potential use in breast cancer treatment.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053724744

Download citation: RISBibTeXText

PMID: 24735798

DOI: 10.1016/j.bbagen.2014.04.006


Related references

Intramolecular disulfide bonds of the prolactin receptor short form are required for its inhibitory action on the function of the long form of the receptor. Molecular and Cellular Biology 29(10): 2546-2555, 2009

Human prolactin receptor variants in breast cancer: low ratio of short forms to the long-form human prolactin receptor associated with mammary carcinoma. Cancer Research 64(16): 5677-5682, 2004

Short form 1b human prolactin receptor down-regulates expression of the long form. Journal of Molecular Endocrinology 44(3): 187-194, 2010

Sequence and functional characterisation of the marmoset monkey (Callithrix jacchus) prolactin receptor: Comparative homology with the human long-form prolactin receptor. Molecular and Cellular Endocrinology 167(1-2): 89-97, 2000

Downregulation of long-form prolactin receptor mRNA during prolactin-induced luteal regression. European Journal of Endocrinology 143(2): 285-292, 2000

Prolactin stimulates cell proliferation through a long form of prolactin receptor and K+ channel activation. Biochemical Journal 377(Pt 3): 569-578, 2004

Generation of mice expressing only the long form of the prolactin receptor reveals that both isoforms of the receptor are required for normal ovarian function. Biology of Reproduction 86(3): 86, 2012

Prolactin-dependent growth and gamma-casein gene expression in Ba/F3 cells transfected with a long form of mouse mammary prolactin receptor. Endocrine Journal 43(1): 45-52, 1996

Induction of brain prolactin receptor long-form mRNA expression and maternal behavior in pup-contacted male rats: promotion by prolactin administration and suppression by female contact. Neuroendocrinology 63(6): 559-568, 1996

A short form of the prolactin (PRL) receptor is able to rescue mammopoiesis in heterozygous PRL receptor mice. Molecular Endocrinology 17(6): 1066-1074, 2003

Variation in the coding and 3' untranslated regions of the porcine prolactin receptor short form modifies protein expression and function. Animal Genetics 45(1): 74-86, 2014

Comparison of long and short forms of the prolactin receptor on prolactin induced milk protein gene transcription. Proceedings of the National Academy of Sciences of the United States of America 88(3): 824-828, 1991

Inhibitory effects of anti-prolactin receptor antibodies on prolactin binding in brain and prolactin-induced feeding behavior in ring doves. Neuroendocrinology 61(2): 125-135, 1995

Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. Molecular Endocrinology 3(9): 1455-1461, 1989

S179D prolactin increases vitamin D receptor and p21 through up-regulation of short 1b prolactin receptor in human prostate cancer cells. Cancer Research 65(16): 7509-7515, 2005